XML 55 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
9 Months Ended
Sep. 30, 2017
Accounting Changes and Error Corrections [Abstract]  
Unaudited Condensed Consolidated Balance Sheet Restatement
Unaudited Condensed Consolidated Balance Sheet
 
 
September 30, 2017
 
 
As previously reported
 
Restatement adjustments
 
As restated
ASSETS
 
 

 
 
 
 
Available-for-sale securities, at fair value (includes pledged securities of $1,309,061,643 for September 30, 2017
 
$
1,304,486,040

 
—

 
1,304,486,040

Mortgage loans held-for-sale, at fair value
 
495,486

 
—

 
495,486

Multi-family loans held in securitization trusts, at fair value
 
1,149,888,917

 
—

 
1,149,888,917

Residential loans held in securitization trusts, at fair value
 
125,403,499

 
—

 
125,403,499

Mortgage servicing rights, at fair value
 
2,993,997

 
—

 
2,993,997

Cash and cash equivalents
 
30,554,867

 
—

 
30,554,867

Restricted cash
 
15,437,341

 
—

 
15,437,341

Deferred offering costs
 
78,432

 
—

 
78,432

Accrued interest receivable
 
8,732,428

 
—

 
8,732,428

Investment related receivable
 
4,699,021

 
—

 
4,699,021

Derivative assets, at fair value
 
—

 
—

 
—

Other assets
 
912,719

 
—

 
912,719

Total assets
 
$
2,643,682,747

 
—

 
2,643,682,747

LIABILITIES AND STOCKHOLDERS' EQUITY
 
 

 
 
 
 
LIABILITIES:
 
 

 
 
 
 
Repurchase agreements:
 
 
 
 
 
 
Available-for-sale securities
 
$
1,237,661,000

 
—

 
1,237,661,000

Multi-family securitized debt obligations
 
1,128,773,402

 
—

 
1,128,773,402

Residential securitized debt obligations
 
119,882,464

 
—

 
119,882,464

Accrued interest payable
 
5,205,165

 
—

 
5,205,165

Derivative liabilities, at fair value
 
529,075

 
—

 
529,075

Dividends payable
 
29,349

 
—

 
29,349

Deferred income
 
202,896

 
—

 
202,896

Due to broker
 
—

 
—

 
—

Fees and expenses payable to Manager
 
587,000

 
—

 
587,000

Other accounts payable and accrued expenses
 
273,732

 
—

 
273,732

Total liabilities
 
2,493,144,083

 
—

 
2,493,144,083

STOCKHOLDERS' EQUITY:
 
 

 
 
 
 
Preferred Stock: par value $0.01 per share; 50,000,000 shares authorized, 8.75% Series A cumulative redeemable, $25 liquidation preference, 1,610,000 issued and outstanding at September 30, 2017
 
37,156,972

 
—

 
37,156,972

Common Stock: par value $0.01 per share; 450,000,000 shares authorized, 22,139,258 shares issued and outstanding, at September 30, 2017
 
221,393

 
—

 
221,393

Additional paid-in capital
 
224,063,268

 
—

 
224,063,268

Accumulated other comprehensive income (loss)
 
(5,643,099
)
 
2,436,690

 
(3,206,409
)
Cumulative distributions to stockholders
 
(100,438,604
)
 
—

 
(100,438,604
)
Accumulated earnings (deficit)
 
(4,821,266
)
 
(2,436,690
)
 
(7,257,956
)
Total stockholders' equity
 
150,538,664

 
—

 
150,538,664

Total liabilities and stockholders' equity
 
$
2,643,682,747

 
—

 
2,643,682,747